Our proprietary ACM technology allows us to produce tailor-made membrane protein products and discovery programs centered around ‘hard’ or ‘difficult-to-express’ targets in drug and vaccine discovery. Examples of membrane proteins that we handle are G protein-coupled receptors (GPCRs), ion channels or transporters, and viral antigens. Most of these membrane protein targets cannot reliably be produced using cell-lines and structurally unstable once produced. ACM technology allows us to use cell free systems and provides enhanced stability and high yields of these targets.

At ACM Biolabs we use our technology for discovery and development of new drugs. This includes by development of our own pipeline of vaccines and antibodies, and also by partnering with leading pharmaceutical companies who use our technology to develop novel drugs.